Researchers at Kansas State University are creating African Swine Fever Virus (ASFV) subunit vaccine candidates using next-generation vectors. Two separate vectors are being utilized to create multiple vaccine candidates to improve the probability of creating a safe, efficacious and economical ASFV vaccine. In addition, KSU has generated a novel chimeric antigen for the development of a sensitive, DIVA (differentiating infected from vaccinated animals) compatible lateral flow diagnostic device. Bret Ford bretford@ksu.edu 785-532-3924
Smart, interactive desk
May 8, 2023
No Comments
Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the